Nicholas Fidelman - Concepedia

Author

Nicholas Fidelman

University of California, San Francisco ORCID

Also Known As

Fidelman, Nicholas, Françoise Smets, N Fidelman, N. Fidelman, NICHOLAS FIDELMAN, Nicholas A. Fidelman, Nicholas Fidelman, Nicholas Fidelman MD, V Agarwal

192

Publications

3.5K

Citations

H-Index

Concepts

All Affiliations

University of California, San Francisco Medical College of Wisconsin Moffitt Cancer Center Oregon Health & Science University University of California System

About

Nicholas Fidelman is an author at University of California, San Francisco specializing in medicine, radiology, and hepatology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	19	32	1.4K
2	Health Sciences	12	14	583
3	Engineering	4	4	428
4	Emergency Medicine	3	3	104
5	Biomedical Engineering	1	1	190

Nicholas Fidelman

Publications

2.6K

Citations

H-Index

Page 1

	Year	Citations
Downstaging of hepatocellular cancer before liver transplant: Long‐term outcome compared to tumors within Milan criteria Francis Y. Yao, Neil Mehta, Jennifer A. Flemming, Hepatology	2015	468
Hepatocellular Carcinoma: Regional Therapy with a Magnetic Targeted Carrier Bound to Doxorubicin in a Dual MR Imaging/ Conventional Angiography Suite—Initial Experience with Four Patients Mark W. Wilson, Robert K. Kerlan, Nicholas Fidelman, Radiology EngineeringOncologic ImagingImaging AgentBiomedical EngineeringNanomedicine	2004	190
Mixed hepatocellular cholangiocarcinoma and intrahepatic cholangiocarcinoma in patients undergoing transplantation for hepatocellular carcinoma Gonzalo Sapisochín, Nicholas Fidelman, John P. Roberts, Liver Transplantation Mixed Hcc-ccTumor RecurrencePathologyCirrhosisOncology	2011	163
Imaging predictors of the response to transarterial chemoembolization in patients with hepatocellular carcinoma: A radiological-pathological correlation Sharon W. Kwan, Nicholas Fidelman, Elizabeth Ma, Liver Transplantation EngineeringOncologic ImagingPathologySurgeryOncology	2012	113
NANETS/SNMMI Consensus Statement on Patient Selection and Appropriate Use of <sup>177</sup>Lu-DOTATATE Peptide Receptor Radionuclide Therapy Thomas A. Hope, Lisa Bodei, Jennifer A. Chan, Journal of Nuclear Medicine EngineeringPatient SelectionPharmacotherapyDifferent Primary OriginRadiation Medicine	2020	113
Complications Associated with the Percutaneous Insertion of Fiducial Markers in the Thorax Nikhil Bhagat, Nicholas Fidelman, Jeremy C. Durack, CardioVascular and Interventional Radiology	2010	111
Embolotherapy for Neuroendocrine Tumor Liver Metastases: Prognostic Factors for Hepatic Progression-Free Survival and Overall Survival James X. Chen, Steven C. Rose, Sarah B. White, CardioVascular and Interventional Radiology Prognostic FactorsSurgical OncologyHepatologyMedicineHepatobiliary Tumor	2016	99
Morbidity and mortality following transarterial liver chemoembolization in patients with hepatocellular carcinoma and synthetic hepatic dysfunction Elisabeth R. Garwood, Nicholas Fidelman, Sarah Hoch, Liver Transplantation	2012	85
Rate of observation and inter-observer agreement for LI-RADS major features at CT and MRI in 184 pathology proven hepatocellular carcinomas Eric C. Ehman, Spencer C. Behr, Sarah E. Umetsu, Abdominal Radiology Inter-observer AgreementHepatologyMedical ImagingHistopathologyPathology	2016	85
Hepatic Arterial Injuries after Percutaneous Biliary Interventions in the Era of Laparoscopic Surgery and Liver Transplantation: Experience with 930 Patients Nicholas Fidelman, Allan I. Bloom, Robert K. Kerlan, Radiology	2008	68

Page 1